Patients on methotrexate show T-cell response to Pfizer vaccineJuly 13, 2021COVID-19 UpdatesDermatologyRheumatologyVaccines
In Black patients, acne scarring might not mean what you thinkJune 25, 2021Diversity in MedicineDermatology
Ruxolitinib cream for atopic dermatitis found to be effective, safe up to 52 weeksJune 25, 2021Dermatology
Survey spotlights the out-of-pocket burden on Blacks with atopic dermatitisJune 25, 2021Diversity in MedicineDermatology
Americans’ sun protection practices fall short of intentionsJune 21, 2021DermatologyPreventive CareOncology
12-month follow-up shows monthly maintenance dose of tralokinumab maintains response in some AD patientsJune 18, 2021Dermatology
Trial offers first look at how tralokinumab-treated patients weather COVID-19June 18, 2021COVID-19 UpdatesDermatology
Intravenous immunoglobulin controls dermatomyositis in phase 3 trialJune 3, 2021RheumatologyDermatologyRare Diseases
